Please update your Flash Player to view content.

Welcome to Main Street EyeCare & Optical

Celebrating Over 20 Years in Honeoye Falls!

Dr. Kissack Dr. Barry Kissack and staff members, Jane, Zach, Erika and Opticians Sally and Amy (see them on Important Info: Our Staff) will be celebrating over 20 years practicing in Honeoye Falls.

Hopefully the information presented here will help you to get to know us better. We are here to serve you with the best eyecare and optical eyewear available.

If you have any questions or concerns feel free to call us or email us through our website. Hope to hear from you soon. Have a great year!

Office Location

Office Map and Directions

Eye Care News

[1/1] MedicineNet Eyesight General
MedicineNet Eyesight General

[1/10] Health Tip: When Something's Stuck in Your Eye

[2/10] Retinal Detachment

[3/10] Study Links Gene to Serious Eye Disease

[4/10] How Sun Time as a Kid Led to Eye Surgery

[5/10] Green Laser Pointers May Be Harmful to Eyes

[6/10] Sjogren's Syndrome

[7/10] Health Tip: Drive Safely in the Dark

[8/10] Health Tip: Why Are My Eyes Red?

[9/10] Lady Gaga-Inspired Lens Fad Draws Warning From Eye Docs

[10/10] Eye Condition May Alter Corneal Transplant Results

[1/1] Eye Health / Blindness News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.

[1/10] Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium

[2/10] 'Back-To-School' How To Prevent Sports Related Eye Injuries

[3/10] Carl Zeiss Meditec Is Shaping The Future Of Ophthalmology: Creating What's To Come

[4/10] OptiMedica's Laser Cataract Surgery System To Be Featured In Three Clinical Presentations At ESCRS 2010

[5/10] Dr. Tom Tooma Purchases Interest In All 12 Southern California TLC Laser Eye Centers, Changing Name To NVISION Laser Eye Centers

[6/10] Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps

[7/10] New Data Will Help Predict Vision Loss In Glaucoma

[8/10] Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results

[9/10] ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By More Than 50 Percent In Patients With Geographic Atrophy

[10/10] Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirms Positive Findings Of First Trial

Important Info

Office Location

Meet Dr. Kissack

Schedule Appointment

EyeCare: 585-624-2585

Optical: 585-624-2122

Affiliations

Social Sites

MySpace

Digg

Delicious

Stumbleupon

Google Bookmarks